Xeris Biopharma Holdings, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
XERS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1375 West Fulton Street, Suite 1300, Chicago, Illinois

Insiders trading volume in the past year

Xeris Biopharma Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul R. Edick Chairman and Chief Executive Officer, Director $7.15M Jan 31, 2024
John Patrick Shannon Jr President and Chief Operating Officer $5.28M +$50.4K +0.96% Jan 31, 2024
Steven Pieper Chief Financial Officer $3.71M +$54.6K +1.49% Jan 31, 2024
Beth Hecht Chief Legal Officer and Corporate Secretary $3.4M Jan 31, 2024
Kevin McCulloch President and Chief Operating Officer $3.11M Aug 1, 2024
John Johnson Director $1.7M Jun 5, 2024
Steven Prestrelski Chief Scientific Officer $1.35M Jan 31, 2023
Kenneth Erland Johnson Senior Vice President, Global Development and Medical Affairs $918K Jan 31, 2024
Jeffrey W. Sherman Director $324K +$10.1K +3.21% Jun 5, 2024
Garheng Kong Director $314K Jun 5, 2024
John P. Schmid Director $311K +$50.1K +19.2% Aug 12, 2024
Ricki Louise Fairley Director $258K Jun 5, 2024
Marla Persky Director $217K +$10.1K +4.85% Jun 5, 2024
Dawn Halkuff Director $216K +$9.95K +4.84% Jun 5, 2024
Kennedy Barbara Bormann Director $205K Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Xeris Biopharma Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.